• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312
Citation: ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312
shu

Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease

  • Jiangsu Key Laboratory of Druggability of Biopharmaceuticals,School of Life Science and Technology, China Pharmaceutical University,Nanjing 211198, China

Funds: This study was supported by the National Natural Science Foundation of China (No. 81673435,No.81872850,No.82073755)
More Information
  • Received Date: January 15, 2021
  • Revised Date: May 16, 2021
    Graphical Abstract
    • Abstract
  • To investigate the effects of VHL (von Hippel-Lindau) inhibitor on Caenorhabditis elegans (C.elegans) model of Parkinson''s disease (PD),C.elegans were exposed to rotenone and treated with VHL inhibitor VH298.The death,dopaminergic neurodegeneration and mitochondrial unfolded protein response (mito-UPR) of transgenic strains with the markers zcIs9 and otIs181 exposed to different concentrations of rotenone were investigated. The death,dopaminergic neurodegeneration,and changes of behaviors including head thrashes,body bends and foraging behavior of C.elegans model of PD treated with different concentrations of VH298 were explored.The results showed that different concentrations of rotenone can lead to the death,dopaminergic neurodegeneration and abnormal mito-UPR of transgenic nematodes with zcIs9; otIs181,while the VHL inhibitor can decrease the death rate and alleviate dopaminergic neurodegeneration of rotenone-induced C.elegans model of PD.The VHL inhibitor can also attenuate the behavioral abnormalities of head thrashes,body bends and foraging behavior of C.elegans model.These results suggest that rotenone may cause mitochondrial damage in the transgenic nematodes with zcIs9; otIs181, and then destroy mitochondrial homeostasis,thereby resulting in dopaminergic neurodegeneration and death of the nematodes. The VHL inhibitor VH298 may promote the survival of rotenone-induced C.elegans model of PD,and alleviate dopaminergic neurodegeneration,thereby improving the behavioral abnormalities of C.elegans model of PD.
    • FullText(HTML)
    • References (17)
  • [1]
    . JAMA，2020，323（6）：548-560.
    [2]
    Martinez BA，Petersen DA，Gaeta AL，et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson''s disease［J］. J Neurosci，2017，37（46）：11085-11100.
    [3]
    Runkel ED，Liu S，Baumeister R，et al. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response［J］. PLoS Genet，2013，9（3）：e1003346.
    [4]
    Schmidt E，Seifert M，Baumeister R. Caenorhabditis elegans as a model system for Parkinson''s disease［J］. Neurodegener Dis，2007，4（2/3）：199-217.
    [5]
    Shaye DD，Greenwald I. OrthoList：a compendium of C. elegans genes with human orthologs［J］. PLoS One，2011，6（5）：e20085.
    [6]
    Kaletta T，Hengartner MO. Finding function in novel targets：C. elegans as a model organism［J］. Nat Rev Drug Discov，2006，5（5）：387-398.
    [7]
    Culetto E，Sattelle DB. A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes［J］. Hum Mol Genet，2000，9（6）：869-877.
    [8]
    Harrington AJ，Hamamichi S，Caldwell GA，et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson''s disease［J］. Dev Dyn，2010，239（5）：1282-1295.
    [9]
    Li J，Le WD. Modeling neurodegenerative diseases in Caenorhabditis elegans［J］. Exp Neurol，2013，250：94-103.
    [10]
    González-Hunt CP，Leung MC，Bodhicharla RK，et al. Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans［J］. PLoS One，2014，9（12）：e114459.
    [11]
    Lehtonen ?，Jaronen M，Vehvil?inen P，et al. Inhibition of excessive oxidative protein folding is protective in MPP（+） toxicity-induced Parkinson''s disease models［J］. Antioxid Redox Signal，2016，25（8）：485-497.
    [12]
    Cooper JF，Dues DJ，Spielbauer KK，et al. Delaying aging is neuroprotective in Parkinson''s disease：a genetic analysis in C. elegans models［J］. NPJ Parkinsons Dis，2015，1：15022.
    [13]
    Chen S，Luo S，Zhang Z，et al. VHL-1 inactivation and mitochondrial antioxidants rescue C. elegans dopaminergic neurodegeneration［J］. Protein Cell，2019，10（8）：610-614.
    [14]
    Stiernagle T. Maintenance of C. elegans［J］. WormBook，2006，11：1-11.
    [15]
    Brenner S. The genetics of Caenorhabditis elegans［J］. Genetics，1974，77（1）：71-94.
    [16]
    Cao X，Wang X，Chen H，et al. Neurotoxicity of nonylphenol exposure on Caenorhabditis elegans induced by reactive oxidative species and disturbance synthesis of serotonin［J］. Environ Pollut，2019，244：947-957.
    [17]
    Tsai CW，Tsai RT，Liu SP，et al. Neuroprotective effects of betulin in pharmacological and transgenic Caenorhabditis elegans models of Parkinson''s disease［J］. Cell Transplant，2017，26（12）：1903-1918.
    • Related Articles

  • Related Articles

    [1]CAI Xu, WU Xiaoqian, HAN Lingfei, FENG Feng, QU Wei, LIU Wenyuan. Research progress on natural products regulating osteogenic differentiation[J]. Journal of China Pharmaceutical University, 2025, 56(1): 10-21. DOI: 10.11665/j.issn.1000-5048.2024101003
    [2]LU Ningshu, JI Tao, LU Yinglan, XU Xiyuan, GU Xiaochen, DING Yang. Drug delivery strategies and clinical research progress for encephalopathy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 577-589. DOI: 10.11665/j.issn.1000-5048.2024063001
    [3]YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
    [4]WANG Chen, ZHANG Zhengping, LI Yinchun. Development strategy and clinical research progress of universal chimeric antigen receptor T-cell drugs[J]. Journal of China Pharmaceutical University, 2023, 54(2): 141-149. DOI: 10.11665/j.issn.1000-5048.20211125001
    [5]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [6]YANG Wanwan, YE Fangyu, WU Yujia, WANG Haochen, ZHAO Li. Research progress of PARP inhibitors in cancers and their drug resistance[J]. Journal of China Pharmaceutical University, 2022, 53(5): 525-534. DOI: 10.11665/j.issn.1000-5048.20220503
    [7]WANG Chen, XU Jun, LIU Yanhua, WANG Zengtao, HU Yue, TIAN Taiping, YI Mengjuan. Research progress on functionalized graphene oxide as drug carriers[J]. Journal of China Pharmaceutical University, 2017, 48(1): 117-124. DOI: 10.11665/j.issn.1000-5048.20170118
    [8]ZHANG Danfeng, JIAO Yu, LIU Yong, ZHANG Yanmin, ZHANG Zhimin, LU Tao. Progress of small molecule anti-tumor covalent drugs[J]. Journal of China Pharmaceutical University, 2017, 48(1): 1-7. DOI: 10.11665/j.issn.1000-5048.20170101
    [9]ZHANG Jinghui, WANG Yajing, HU Rong. Roles of Moesin in tumor progression[J]. Journal of China Pharmaceutical University, 2015, 46(3): 371-375. DOI: 10.11665/j.issn.1000-5048.20150319
    [10]Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80.

  • Cited by

    Periodical cited type(10)

    1. 严欣，胡蝶，贾瑞瑞，华雅洁，岳远征，王良桂，杨秀莲. 海州常山组培再生体系的建立. 分子植物育种. 2022(04): 1297-1303 .
    2. 郝丽亚，李冰洁，王中林，郑新华. 扯根菜化学成分及其保肝活性. 中成药. 2022(09): 2848-2854 .
    3. 张宇，岑银芝，陈亮，李勇军，孙建博，李林珍. 海州常山茎的化学成分研究(Ⅱ). 中药材. 2022(04): 857-861 .
    4. 王啸洋，卫柯，陆云阳，佟菲，张艳华，汤海峰. 美花铁线莲茎乙醇提取物正丁醇萃取部位化学成分的提取和鉴定. 环球中医药. 2022(11): 1784-1790 .
    5. 李林珍，张宇，陈亮，岑银芝，涂杨丽，杨小生，李勇军. 海州常山茎正丁醇部位的化学成分及体外抗肿瘤活性研究. 中国药房. 2022(21): 2578-2583+2589 .
    6. 刘晓聪，林冬梅，刘敏，张敏，李强，王健，徐露琳，高原，杨健. 番石榴的化学成分及其抗肿瘤与抗真菌活性. 中国中药杂志. 2021(15): 3877-3885 .
    7. 陈林玉，宋乐园，王云雨，卢梦如，顿彩云，杨青华，毕跃峰. 红小米化学成分与营养成分分析. 食品科学. 2021(18): 218-224 .
    8. 张吕丽，吴云飞，李祖强，罗蕾. 柄果海桐化学成分研究(Ⅲ). 云南师范大学学报(自然科学版). 2020(02): 55-58 .
    9. 吴威，宋芷琪，田琨宇，张会永. 豨桐丸的本草考证及组方药物化学成分和药理作用研究进展. 中草药. 2020(17): 4586-4597 .
    10. 刘璐，张宇，魏茜，李勇军，杨小生，李林珍. 臭梧桐子化学成分研究. 中药材. 2020(07): 1622-1625 .

    Other cited types(8)

Catalog

    Get Citation
    PDF
    XML
    Article views (291) PDF downloads (720) Cited by(18)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292790

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return